Abstract A common strategy for conditional knockout alleles is to ''flox'' (flank with loxP sites) a 5 0 exon within the target gene. Typically, the floxed exon does not contain a unit number of codons so that the Cre-mediated recombination event yields a frameshift and a null allele. Documenting recombination within the genomic DNA is often regarded as sufficient proof of a frameshift, and the analysis of transcripts is neglected. We evaluated a previously reported conditional knockout allele for the b-subunit of protein farnesyltransferase. The recombination event in that allele-the excision of exon 3-was predicted to yield a frameshift. However, following the excision of exon 3, exon 4 was skipped by the mRNA splicing machinery, and the predominant transcript from the mutant allele lacked exon 3 and exon 4 sequences. The ''Dexon 3-4 transcript'' does not contain a frameshift but rather is predicted to encode a protein with a short in-frame deletion. This represents a significant concern when studying an enzyme, since an enzyme with partial function could lead to erroneous conclusions. With thousands of new conditional knockout alleles under construction within mouse mutagenesis consortiums, the protein farnesyltransferase allele holds an important lesson-to characterize knockout alleles at both the DNA and RNA levels.
Introduction
In preparing a conditional knockout allele, loxP sites are typically inserted into different introns of a target gene (''floxing'' an exon or exons) (Kühn et al. 1995; Rajewsky et al. 1996; Schwenk et al. 1995) . With the expression of Cre recombinase, the exon(s) of the gene is removed, resulting in a knockout allele. Typically, care is taken to ''flox'' an exon without a unit number of codons (i.e., an exon where the number of nucleotides in the exon is not evenly divisible by three) so that the recombination event yields a frameshift. A frameshift is important for creating a null allele (Hasty et al. 2000) . Other considerations relevant to producing a null allele have been reviewed by Hasty et al. (2000) .
A conditional knockout allele for Fntb, the gene encoding the b-subunit of protein farnesyltransferase (FTase), was reported by Mijimolle et al. (2005) . FTase catalyzes the farnesylation (covalent attachment of a 15-carbon isoprenyl lipid) of proteins carrying a carboxyl-terminal CaaX motif (Casey and Seabra 1996) . In Mijimolle's Fntb conditional knockout allele (Mijimolle et al. 2005) , exon 3 (73 bp in length) was flanked by loxP sites. As expected, the expression of Cre recombinase excised exon 3, and that recombination event was well characterized at the genomic DNA level (Mijimolle et al. 2005) . The excision of exon 3 was predicted by Mijimolle et al. (2005) to yield a frameshift and a null allele, but transcripts from the allele were not analyzed.
Without question, the Cre-mediated excision of exon 3 reduced FTase activity. Germline homozygosity for the recombined allele prevented normal embryonic development, and fibroblasts homozygous for the mutant allele had reduced FTase activity (Mijimolle et al. 2005) . On the other hand, several features of Mijimolle's study (Mijimolle et al. 2005) were unexpected. For example, in homozygous knockout fibroblasts, H-RAS remained associated with membrane fractions (Mijimolle et al. 2005) . That was peculiar because the association of H-RAS with membranes is utterly dependent on protein farnesylation (Berzat et al. 2005 (Berzat et al. , 2006 Chenette et al. 2005; Takahashi et al. 2005) . The prenylation of another farnesylated protein, HDJ-2, was only partially blocked in their homozygous Fntb-deficient fibroblasts (Mijimolle et al. 2005) . Also, the Fntb knockout had no effect on tumorigenesis, while FTase inhibitor drugs retard tumor growth (Barrington et al. 1998; Omer et al. 2000) .
In this study, we examined the Fntb allele generated by Mijimolle et al. (2005) . We found that the predominant transcript produced by the mutant allele did not contain a frameshift but rather encoded a protein with a short in-frame deletion. (Todaro and Green 1963) . Mouse embryonic fibroblasts (MEFs) (80% confluent) grown on 6-well plates were infected with Cre adenovirus (20 ll/well, 3 9 10 10 pfu/ml, Gene Transfer Vector Core, University of Iowa), and cells extracts were prepared 5 days later. In some experiments, cells were treated with Cre adenovirus only once. A single treatment with Cre adenovirus generally did not lead to 100% complete recombination; however, those experiments were nevertheless useful because they allowed us to analyze Cre-recombination events.
Materials and methods

Genetically modified mice
In other experiments, Cre adenovirus treatment was repeated three times, so as to yield complete recombination. Before harvesting the latter cells, genotyping was performed to make sure that the genotype. In some experiments, fibroblasts were treated with a protein farnesyltransferase inhibitor (FTI) (ABT-100, 5 lM) (Ferguson et al. 2005 ).
RT-PCR reactions
RT-PCR products were obtained from Fntb lox and Fntb D alleles with exon1/exon5, exon1/exon8, and exon1/ exon4 primer sets. Exon 1 forward primer: 5 0 -TACAG CGCTCGCAGCTCTCC-3 0 ; exon 5 reverse primer: 5 0 -CATTGACGGCTGCATAAGTG-3 0 ; exon 8 reverse primer: 5 0 -GCCAAGCCACAGAAGGTGTA-3 0 ); exon 4 reverse primer: 5 0 -CTGCTACTGGATCCTGCAC A-3 0 . Total RNA was extracted from MEFs or tissues with the RNeasy Mini kit (Qiagen); reverse transcriptase reactions were carried out with 500 ng of RNA that had been treated with DNase (DNA-Free, Ambion), Superscript III (Invitrogen), and a mixture of oligo-dT (Invitrogen) and random primers (Invitrogen). The thermal cycling conditions were as follows: 95°C for 3 min, 95°C for 15 s, 60°C for 30 s, and 72°C for 15 s, for a total of 26 cycles.
Western blots
Cell extracts were electrophoresed on 4-12% gradient polyacrylamide Bis-Tris gels (Invitrogen), and the proteins were electrophoretically transferred to a nitrocellulose membrane for western blotting. The antibody dilutions were 1:400 for anti-lamin A/C goat IgG (sc-6215, Santa Cruz Biotechnology), 1:500 for anti-HDJ-2 mouse IgG (NeoMarkers), and 1:1000 for anti-actin goat IgG (sc-1616, Santa Cruz Biotechnology). After washing the membrane, the blots were incubated with secondary antibodies (1:5000 IRDye 700 anti-goat IgG antibody and 1:5000 IRDye 800 anti-mouse IgG antibody). Signals were detected with the Odyssey infrared imaging system (LI-COR Biosciences).
Results and discussion
We generated Fntb lox/D MEFs and incubated them with Cre adenovirus (Anton and Graham 1995) or an adenovirus encoding b-galactosidase. As expected, the floxed segment of DNA (spanning exon 3) was removed by Cre recombinase (Fig. 1a, b) . The location of the loxP sites in the Fntb lox allele was documented by DNA sequencing. As noted earlier, the excision of exon 3 was predicted to yield a frameshift (Mijimolle et al. 2005) . To characterize the transcripts from the mutant allele, we performed RT-PCR reactions spanning sequences encoded by exons 1-5 and exons 1-8 (Fig. 2a-c) . Following the excision of exon 3 from the genomic DNA, exon 4 was skipped by the mRNA splicing machinery. Thus, the predominant transcript from the Fntb D allele in Fntb lox/D MEFs lacked exon 3 and exon 4 sequences (Fig. 2b, c) . After a single round of Cre adenovirus infection, the amount of ''Dexon 3-4 transcript'' was substantial, but some non-recombined (wild-type) transcripts remained (Fig. 2b) . To achieve complete recombination, we treated Fntb lox/D MEFs with three rounds of Cre adenovirus (Fig. 2c) . In the latter cells, none of the wild-type Fntb transcript remained.
The identity of the RT-PCR product corresponding to the ''Dexon 3-4 transcript'' was confirmed by DNA sequencing (Fig. 2d) . The Dexon 3-4 transcript was the predominant transcript from the Fntb D allele within the tissues of Fntb lox/D mice (Fig. 2e) . The Dexon 3-4 transcript is predicted to encode a protein with an in-frame deletion of amino acids 70-124.
As judged by ethidium bromide-stained agarose gels of RT-PCR reactions, the levels of the Dexon 3-4 transcript in Fntb lox/D MEFs and mouse tissues were comparable to those of the wild-type Fntb transcript (Fig. 2b, c, e) . Finding high levels of the Dexon 3-4 transcript was not surprising because the Dexon 3-4 transcript lacks a premature stop codon and would not be subject to nonsense-mediated mRNA decay.
Trace amounts of a Dexon 3 RT-PCR product could be detected between the wild-type and Dexon 3-4 RT-PCR products (Fig. 2b, e) . The identity of the Dexon 3 RT-PCR product was confirmed by DNA sequencing (not shown). The Dexon 3 transcript could also be detected by RT-PCR with an exon1/ exon4 primer set (this primer set cannot detect the Dexon 3-4 transcript) (Fig. 2f, g ). The level of the Dexon 3 transcript, relative to the wild-type transcript, was low (Fig. 2b, e) .
Prelamin A and HDJ-2 are both CaaX proteins that are farnesylated by FTase. In Cre adenovirus-treated Fntb lox/D MEFs (three rounds of infection), we found that HDJ-2 prenylation was blocked by only 50% (Fig. 3a) . These results were essentially identical to the findings reported earlier by Mijimolle et al. (2005) ; they had produced Fntb D/D fibroblasts from a single cell clone and found that only *50% of HDJ-2 prenylation was blocked. In control experiments with wild-type fibroblasts, we found that a pharmacologic inhibitor of FTase blocked almost all HDJ-2 farnesylation (Fig. 3a) .
We also found small amounts of prelamin A accumulation in these cells, indicating a partial blockade of lamin A biogenesis (Fig. 3b) . Normally, prelamin A is efficiently converted to mature lamin A and prelamin A is virtually undetectable in cells. In the absence of farnesylation, prelamin A cannot be converted to mature lamin A and nonfarnesylated prelamin A accumulates in cells. Interestingly, the amount of prelamin A in Cre adenovirus-treated Fntb lox/D MEFs was small but increased when the cells were treated with an FTI (Fig. 3b) . The existence of nonfarnesylated HDJ-2 and prelamin A in Cre adenovirus-treated Fntb lox/D MEFs provided unequivocal evidence for markedly reduced FTase activity. On the other hand, the effects of the Fntb gene inactivation on HDJ-2 prenylation and lamin A biogenesis were less than we would have expected with a complete Fntb knockout. Also, we observed greater inhibition of HDJ-2 prenylation when Cre adenovirus-treated Fntb lox/D MEFs were treated with an FTase inhibitor Yang et al. 2005) .
At this point, we do not know if a mutant b-chain lacking amino acids 70-124 would be able to associate with the a-chain and yield an FTase complex with residual enzymatic activity. However, this possibility is not farfetched; deletions of [100 amino acids from the amino terminus of the b-subunit of yeast FTase do not prevent association with the a-chain (Urano et al. 2000) . We also do not know if the internally truncated b-chain would yield a prenyltransferase with altered specificities. Addressing these issues with biochemical studies would be extremely challenging. In fact, we believe that biochemical experiments to fully exclude trace amounts of residual FTase activity from Mijimolle's Fntb D allele (and biochemical experiments to unequivocally prove that the prenylation in Fntb D/D cells is due to geranylgeranyltransferase, type I) would be virtually impossible and ultimately would yield murky results.
In some knockout experiments, a 99.5%-complete knockout might be entirely satisfactory. However, when the goal is to investigate the physiologic importance of FTase, a ''leaky'' knockout allele is suboptimal. When faced with an in-frame deletion and the possibility of an enzyme with partial function, one should strongly consider generating a new conditional knockout allele.
In constructing their conditional Fntb knockout allele, Mijimolle et al. (2005) reported that they had deleted 967 bp of intron 2 and 297 bp of intron 3. Based on their paper, the intron 2 deletion started 114 bp 5 0 to the intron 2-exon 3 junction, and the intron 3 deletion started 146 bp 3 0 to the exon 3-intron 3 junction. These descriptions did not match our DNA sequencing data; the deletions started 155 bp 5 0 and 88 bp 3 0 to exon 3. We believe that introducing deletions this close to intron-exon junctions is hazardous, and we would not be surprised if the intron deletions contributed to the aberrant mRNA splicing. In any case, we suspect that the aberrant splicing event in Mijimolle's Fntb allele would have been overlooked by many laboratories. Conditional knockout alleles are almost always well characterized at the genomic DNA level, and the excision of an exon is widely regarded as proof of a null allele. The transcripts from knockout alleles are often not characterized, even when experimental findings raise the possibility of a leaky allele (Mijimolle et al. 2005) . The NIH has funded the Knockout Mouse Project (KOMP) to create a toolbox of mutant mouse alleles for the biomedical research community (Collins et al. 2007a, b) . Thousands of conditional knockout alleles are now being generated. KOMP investigators introduce a loxP site and a ''splice acceptor-lacZ reporter cassette'' into one intron and a second loxP site into another intron (Collins et al. 2007b ). The initial targeting event yields a knockout allele containing a b-galactosidase reporter. However, the lacZ cassette (which is flanked by FRT sites) can be excised with Flp recombinase, creating a conditional knockout allele in which an exon(s) is flanked by loxP sites (i.e., an allele that is structurally similar to the one created by Mijimolle et al. 2005) . The studies reported here suggest that caution is warranted with conditional knockout alleles. In experiments with these alleles, whether they are obtained from KOMP or elsewhere, it is important to consider the possibility of unexpected splicing events. This is particularly important for any project where the creation of a true null allele is deemed important.
